Geo Group IncGEO

GEO Group Inc reported revenue of $705.2M for the quarter ending 31 March 2026, a figure that sits awkwardly beside net income of $38.3M and operating income of $89.3M. The company’s cash-generative core is real-$156.5M of operating cash flow-but the cash itself is thin on the ground at just $80.2M, while $41.0M sits tied up in inventory that reads more like unsold real estate than working capital. The filings are clear: this is a business that collects payments from governments and counties, not a tech platform with recurring SaaS magic.

GEO’s two operating divisions speak to its purpose: GEO Secure Services designs, builds and operates secure facilities, managing roughly 62,000 beds across 51 facilities worldwide, while GEO Reentry Services runs non-residential centres that have delivered structured transition programmes since 1996. The product pages are slick, but the customer base is narrow-mostly state and county correctional agencies-and the contracts are subject to political winds and budget cycles. The company’s own language admits the operating structure is regional, designed to keep quality controls tight and relationships personalised, yet the filings do not show a diversified revenue base.

The latest 10-Q for the quarter ending 31 March 2026 shows $705.2M of revenue, $89.3M of operating income, $38.3M of net income attributable to the parent, and diluted EPS of $0.29 on 134.1M weighted average shares outstanding. Cash and cash equivalents stood at $80.2M, while stockholders’ equity totalled $1.50B against total assets of $3.81B. Capital expenditure for the quarter was $21.7M, and operating cash flow was $156.5M.

The company’s continuous disclosure page on SEC EDGAR lists the full filing index, but the 13G filings from May 2026 show passive investors accumulating shares without any accompanying narrative about strategy or catalyst. The 11-K filed 25 June 2026 confirms the structure but adds no new numbers. The share count remains diluted at 134.1M, and there is no evidence of a substantive buyback programme-only the optics of an advisory vote on executive compensation approved on 4 May 2026. The gap between the rehabilitation narrative and the financial ledger is measurable in dollars, not platitudes.

The company’s own product pages trumpet ‘evidence-based’ and ‘cognitive behavioural treatment’, but the balance sheet shows a business that spends more on facilities than it keeps in the bank. The cash flow is healthy on an absolute basis, yet the cash position is light relative to the scale of operations. The filings do not contain segment-level profitability, so the reader cannot see which beds are most profitable or whether the reentry centres are margin-accretive. The evidence ends at the 10-Q line items; there is no deeper disclosure.

For readers seeking a chart, the SEC does not provide one; TradingView or your broker’s terminal will have to suffice for price action, which is outside this evidence set. The servicing business is not a growth equity with multiple expansion stories-it is a contracted cash-flow generator with political and budgetary risk baked into every facility lease and service agreement. The filings do not include forward-looking guidance, so the next move in revenue, margins or cash is anyone’s guess beyond the next quarterly report.